Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for IRIDEX Corporation (IRIX : NSDQ)
 
 • Company Description   
IRIDEX Corporation is the leading worldwide provider of semiconductor-based laser systems used to treat eye diseases in ophthalmology and skin lesions in dermatology. The products are sold in the United States predominantly through a direct sales force and internationally through independent distributors. The company markets the products using three brand names: IRIS Medical to the ophthalmology market, IRIDERM to the dermatology market, and Light Solutions to the research market.

Number of Employees: 93

 
 • Price / Volume Information   
Yesterday's Closing Price: $1.04 Daily Weekly Monthly
20 Day Moving Average: 674,611 shares
Shares Outstanding: 17.31 (millions)
Market Capitalization: $18.00 (millions)
Beta: 0.75
52 Week High: $1.65
52 Week Low: $0.87
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -21.81% -26.24%
12 Week -33.33% -34.73%
Year To Date -8.77% -11.08%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
1212 Terra Bella Avenue
-
Mountain View,CA 94043
USA
ph: 650-940-4700
fax: 650-940-4710
investors@iridex.com http://www.iridex.com
 
 • General Corporate Information   
Officers
Patrick Mercer - Chief Executive Officer
Scott Shuda - Chairperson of the Board
Romeo R. Dizon - Chief Financial Officer
Beverly A. Huss - Director
William Moore - Director

Peer Information
IRIDEX Corporation (CYBE)
IRIDEX Corporation (QPCI)
IRIDEX Corporation (CLZR)
IRIDEX Corporation (DYSL)
IRIDEX Corporation (XLTC)
IRIDEX Corporation (PLSIQ)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: LASERS-SYS/COMP
Sector: Computer and Technology
CUSIP: 462684101
SIC: 3845
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 12/01/25
Next Expected EPS Date: 05/12/26
Share - Related Items
Shares Outstanding: 17.31
Most Recent Split Date: (:1)
Beta: 0.75
Market Capitalization: $18.00 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 05/12/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: 0.34
EPS Growth
vs. Year Ago Period: 80.00%
vs. Previous Quarter: 88.89%
Sales Growth
vs. Year Ago Period: 15.97%
vs. Previous Quarter: 17.94%
ROE
03/31/26 - -
12/31/25 - -
09/30/25 - -1,204.74
ROA
03/31/26 - -
12/31/25 - -14.39
09/30/25 - -16.50
Current Ratio
03/31/26 - -
12/31/25 - 1.91
09/30/25 - 1.94
Quick Ratio
03/31/26 - -
12/31/25 - 1.32
09/30/25 - 1.35
Operating Margin
03/31/26 - -
12/31/25 - -8.42
09/30/25 - -10.04
Net Margin
03/31/26 - -
12/31/25 - -8.42
09/30/25 - -10.04
Pre-Tax Margin
03/31/26 - -
12/31/25 - -8.32
09/30/25 - -9.98
Book Value
03/31/26 - -
12/31/25 - -0.06
09/30/25 - -0.08
Inventory Turnover
03/31/26 - -
12/31/25 - 3.96
09/30/25 - 3.41
Debt-to-Equity
03/31/26 - -
12/31/25 - -
09/30/25 - -
Debt-to-Capital
03/31/26 - -
12/31/25 - 43.14
09/30/25 - 44.18
 

Powered by Zacks Investment Research ©